A researcher from The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) has received a joint appointment as the leader of a new initiative of CSIRO.
Patients at risk of life-threatening infections following chemotherapy could benefit from a new cell-based treatment developed from University of Queensland research.